Figure 2.
Subgroup analysis for the primary efficacy endpoint. ACS, acute coronary syndrome; BMS, bare-metal stent; CAD, coronary artery disease; CI, confidence interval; DES, drug-eluting stent; HR, hazard ratio; ISR, in-stent restenosis; MLD, minimum lumen diameter; n, number of patients with event; N, number of patients assigned to the treatment; RVD, reference vessel diameter.